Notice to the annual general meeting of Orion Corporation

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
138
Notice to the annual general meeting of Orion Corporation

ORION CORPORATION         STOCK EXCHANGE RELEASE 8 FEBRUARY 2017 at 12.30 EET                       

Notice to the annual general meeting of Orion Corporation

Notice is given to the shareholders of Orion Corporation to the Annual General Meeting to be held on Wednesday 22 March 2017 at 2:00 p.m. Finnish time in Messukeskus Helsinki, Exhibition and Convention Centre, address: Messuaukio 1, Helsinki. The reception of the participants and the distribution of the voting tickets will start at 1:00 p.m. Coffee will be served after the meeting.

A. Agenda of the Meeting, in the order of handling
   
1. Opening of the Meeting
   
2. Matters of order for the Meeting
   
3. Election of the person to confirm the minutes and the persons to verify the counting of votes
   
4. Recording the legal convening of the Meeting and quorum
   
5. Recording the attendance at the Meeting and the list of votes
   
6. Presentation of the Financial Statements 2016, the report of the Board of Directors and the Auditor's report
   
        -  Review by the President and CEO
   
7. Adoption of the Financial Statements
   
8. Decision on the use of the profits shown on the Balance Sheet and the payment of the dividend
   
  The Board of Directors proposes that a dividend of EUR 1.35 per share and in addition, in honor of Orion's centenary, an extra dividend of EUR 0.20 per share, i.e., in total a dividend of EUR 1.55 per share be paid on the basis of the Balance Sheet confirmed for the financial year that ended on 31 December 2016. According to the proposal, the dividend is paid to Orion Corporation shareholders entered in the Company's register of shareholders maintained by Euroclear Finland Ltd on the record date, 24 March 2017. The date of the dividend payment is 31 March 2017.   Shareholders having not registered their shares in the book-entry system by the record date for dividend payment shall receive the dividend payment only after registration of their shares in the system.
   
9. Decision on the discharge of the members of the Board of Directors and the President and CEO from liability
   
10. Decision on the remuneration of the members of the Board of Directors
   
  The Company's Nomination Committee has announced as its recommendation that the following remunerations be paid to the Board of Directors:      As an annual fee, the Chairman would receive EUR 84,000, the Vice Chairman would receive EUR 55,000 and the other members would receive EUR 42,000 each. As a fee for each meeting attended, the Chairman would receive EUR 1,200, the Vice Chairman would receive EUR 900 and the other members would receive EUR 600 each. The travel expenses of the Board members would be paid in accordance with previously adopted practice. The aforementioned fees would also be paid to the Chairmen and to the members of the committees established by the Board, for each committee meeting attended.      Of the annual fee, 60% would be paid in cash and 40% in Orion Corporation B-shares, which would be acquired to the members during 27 April-4 May 2017 from the stock exchange in amounts corresponding to EUR 33,600 for the Chairman, EUR 22,000 for the Vice Chairman and EUR 16,800 for each of the other members. The part of the annual fee that is to be paid in cash corresponds to the approximate sum necessary for the payment of the income taxes on the fees and would be paid no later than 31 May 2017. The annual fees shall encompass the full term of office of the Board of Directors.               In addition, the Company would pay the transfer tax related to the part of the annual fee of the Board of Directors paid in shares.       The Nomination Committee has not given its recommendation for the remunerations to the Board of Directors, but the matter will be proposed by a shareholder at the AGM.  
   
11. Decision on the number of members of the Board of Directors
   
  In accordance with the recommendation by the Company's Nomination Committee, the Board of Directors proposes to the Annual General Meeting that the number of the members of the Board of Directors be seven.  
   
12. Election of the members and the Chairman of the Board of Directors
   
  In accordance with the recommendation by the Nomination Committee, published by Stock Exchange Release on 24 January 2017, the Board of Directors proposes to the Annual General Meeting that of the present Board members, Sirpa Jalkanen, Timo Maasilta, Eija Ronkainen, Mikael Silvennoinen and Heikki Westerlund would be re-elected and M.Sc. (Eng.) Ari Lehtoranta and Professor Hilpi Rautelin would be elected as new members for the next term of office.       Heikki Westerlund would be elected as Chairman.        Of the present members, Hannu Syrjänen and Jukka Ylppö, who both have served as members of the Board of Directors for 10 consecutive years, have informed that they are no longer available for re-election.        Essential personal data of Ari Lehtoranta:   Born: 1963   Education and profession: M.Sc. (Eng.), President and Chief Executive Officer, Caverion Corporation   Essential work experience:   Caverion Corporation, President and Chief Executive Officer, 2017- Nokian Tyres plc, President and Chief Executive Officer, 2014-2016 KONE Corporation, Executive Vice President, Central and North Europe, 2010-2014 KONE Corporation, Executive Vice President, Major Projects, 2008-2010 Nokia Siemens Networks/Nokia Networks, Head of Radio Access, 2005-2008 Nokia Corporation, Vice President of Operational Human Resources, 2003-2005 Nokia Networks, Head of Broadband Division, Head of Systems Integration and Customer Services for Europe, 1999-2003 Nokia Telecommunications, Managing Director in Italy and various other positions, 1985-2003.   Current key positions of trust:   Ilmarinen Mutual Pension Insurance Company, Member of the Supervisory Board, 2015-   Former key positions of trust:   Caverion Corporation, Chairman of the Board of Directors 2015-2016, Member of the Board of Directors 2013-2015   Essential personal data of Hilpi Rautelin:   Born: 1961   Education and profession: Professor, M.D., Ph.D., Specialist in Clinical Microbiology   Essential work experience:   Uppsala University, Sweden, Professor of Clinical Bacteriology, 2008- University of Helsinki, Finland, Research and teaching positions in 1986-2016: Clinical Lecturer 2002-2016 (part time 2008-2016), Research Associate 1996-2002 More than 140 peer-reviewed original articles mainly on Microbiology and Infectious Diseases published in international scientific journals   Current key positions of trust:   Arvo and Lea Ylppö Foundation, Member of the Board of Directors, 2011- European Union of Medical Specialists UEMS, Section of Medical Microbiology, President, 2012-   Spouse: Jukka Ylppö  
   
13. Decision on the remuneration of the Auditor
   
  In accordance with the recommendation by the Board's Audit Committee, the Board of Directors proposes to the Annual General Meeting that the remunerations to the Auditor be paid on the basis of invoicing approved by the Company.  
   
14. Election of the Auditor
   
  In accordance with the recommendation by the Board's Audit Committee, the Board of Directors proposes to the Annual General Meeting that Authorised Public Accountants PricewaterhouseCoopers Oy be elected as the Company's Auditor.
   
15. Proposal by the Board of Directors to amend Sections 5 and 9(1) of the Articles of Association  
  The Board of Directors proposes to the Annual General Meeting that section 5 of the Articles of Association be amended so that the last sentence of section 5 concerning the maximum age (67 years) of a person to  be elected member of the Board of Directors be removed. Due to the amendment, section 5 of the Articles of Association would in its entirety be as follows:   "The Board of Directors shall comprise at least five (5) and at most eight (8) members. The term of the members of the Board of Directors shall end at the end of the Annual General Meeting of the Shareholders following the election. The General Meeting of the Shareholders shall elect the Chairman of the Board of Directors and the Board of Directors shall elect the Vice Chairman of the Board of Directors, both for the same term as the other members."   The Board of Directors additionally proposes that the first paragraph of section 9 of the Articles of Association be amended to correspond to the amended wording of the Auditing Act. Due to the amendment, the first paragraph of section 9 of the Articles of Association would in its entirety be as follows:     "The company shall have one auditor, which shall be Authorised Public Accountants."  
16. Closing of the Meeting  
   
B. Documents of the Annual General Meeting
   
  The unofficial English versions of the proposals of the Board of Directors and of the recommendation of the Nomination Committee as well as this Notice to the Annual General Meeting are available on the website of Orion Corporation, at www.orion.fi. The Financial Statement documents of Orion Corporation, which include the Financial Statements, the Report of the Board of Directors and the Auditor's Report, will be available on the above-mentioned website no later than 1 March 2017. The proposals of the Board of Directors and the Financial Statement documents will also be available at the Annual General Meeting.  
   
C. Instructions for the participants in the Annual General Meeting
   
1. The right to participate and registration
   
  Shareholders being registered in the Company's register of shareholders, maintained by Euroclear Finland Ltd, on 10 March 2017 have the right to attend the Annual General Meeting. A shareholder, whose shares are registered on his/her personal Finnish book-entry account, is registered in the Company's register of shareholders.   A shareholder, who intends to participate in the Annual General Meeting, shall register for the Meeting by giving a prior notice of participation to the Company no later than 16 March 2017 at 6:00 p.m. Finnish time. The notice can be given in either of the following ways:                     a)Electronically through Internet, at www.orion.fi             b)By telephone to +358 10 426 5252 (Monday-Friday 8:00 a.m. - 6:00 p.m.)            c)By letter to Orion Corporation, Treasury, P.O.Box 65, FI-02101 Espoo, Finland.          In the registration, a shareholder shall notify his/her name, personal identification code or the company code, address, phone number and the name and the personal identification of a possible assistant or proxy representative. The personal registering details submitted to Orion Corporation will only be used in connection with the Annual General Meeting and necessary registrations relating to it. A shareholder, his/her representative or proxy representative shall, on demand, be able to prove their identity and/or right to representation at the venue.  
   
2. Holders of nominee-registered shares
   
  A holder of nominee registered shares has the right to participate in the Annual General Meeting on the basis of those shares as would entitle him/her to be registered in the shareholder register maintained by Euroclear Finland Ltd on 10 March 2017. Additionally, the holder of those shares is requested to be temporarily entered in the shareholder register maintained by Euroclear Finland Ltd no later than 17 March 2017 at 10:00 a.m. Finnish time. For nominee registered shares, this constitutes due registration for the Annual General Meeting.   A holder of nominee registered shares is advised to request early enough the necessary instructions concerning the temporary registration in the Company's register of shareholders, the issuing of proxy documents and the registration for the Annual General Meeting from his/her custodian bank. The holder of nominee registered shares who aims to participate in the Annual General Meeting, must be temporarily entered by the custodian bank in the Company's register of shareholders no later than the above-mentioned time.
   
3. Proxy representation and powers of attorney
   
  A shareholder may participate in the Annual General Meeting and exercise his/her rights at the Meeting by way of proxy representation. A proxy representative shall present a dated proxy document or otherwise in a reliable manner demonstrate his/her right to represent the shareholder at the Meeting. If a shareholder attends the Meeting by way of several proxy holders representing the shareholder with shares entered in different security accounts, the shares represented by each proxy holder must be identified when registering for the Annual General Meeting.   Possible proxies are requested to be delivered in originals to Orion Corporation, Treasury, P.O.Box 65, FI-02101 Espoo, Finland, before the end of the registration period.
   
4. Other information
   
  Pursuant to chapter 5, section 25 of the Companies Act, a shareholder who is present at the Annual General Meeting has the right to request information on the matters dealt with at the Meeting.   On 8 February 2017, the date of the Notice to the Annual General Meeting, the total number of shares in Orion Corporation is 141,257,828, of which 38,100,273 are Class A shares and 103,157,555 Class B shares. The total number of votes is 865,163,015, of which Class A shares account for 762,005,460 votes and Class B shares for 103,157,555 votes.   
   

Espoo, 8 February 2017

Orion Corporation Board of Directors

Orion Corporation

Timo Lappalainen President and CEO   Olli Huotari SVP, Corporate Functions  

                                                                                                                                    Contact person: Timo Lappalainen, President and CEO, phone +358 10 426 3692 Olli Huotari, Senior VP, Corporate Functions, Secretary of the Board of Directors, phone +358 50 966 3054

Publisher: Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland Homepage: www.orion.fi

Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs. Orion's net sales in 2016 amounted to EUR 1,074 million and the company had about 3,500 employees. Orion's A and B shares are listed on Nasdaq Helsinki. Founded in 1917, Orion celebrates its centennial anniversary in 2017.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Avive Partners with Cambridge Fire for Lifesaving Training

Updated Category News Views 4

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 4

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Feeding Families Foundation Gains $121,500 for NYC Push

Updated Category News Views 2

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 5

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 3

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 6

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 2

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 5

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 5

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Update for Paragon 28, Inc. Investors: Join the Class Action

Updated Category News Views 63

Understanding the Paragon 28, Inc. Class Action Lawsuit In recent developments within the financial sector, Paragon 28, Inc. has found itself at the center of a class action lawsuit that affects many of its investors. This article will provide crucial information regarding the legal proceedings and what it means for shareholders who are impacted. Who Filed the Class...

Continue Reading
Investigating Allegations Against DexCom, Inc. for Investors

Updated Category News Views 145

Understanding the Investigation of DexCom, Inc. In recent developments, Kaskela Law LLC has announced an investigation into DexCom, Inc. for potential breaches of fiduciary duty. This move aims to support the company's long-term shareholders who may be affected by recent market events. Background of the Situation The investigation follows a securities fraud complaint that...

Continue Reading
Blain’s Farm & Fleet Shines in Newsweek’s Best Online Shops

Updated Category News Views 89

Blain’s Farm & Fleet Achieves Recognition for Online Excellence Blain's Farm & Fleet, a well-respected name in retail, has been honored as one of Newsweek’s Best Online Shops for 2025. This recognition marks the fourth consecutive year the company has earned this prestigious title, reflecting its unwavering commitment to quality and service across its online platform....

Continue Reading
Urgent Safety Alert for Uomeod Mini Steamers Due to Burns

Updated Category News Views 254

Urgent Warning Regarding Uomeod Mini Steamers The U.S. Consumer Product Safety Commission (CPSC) has issued a crucial warning to all consumers regarding the Uomeod Mini Steamers. Due to serious burn hazards associated with hot water ejections, immediate cessation of use is necessary. Details of the Burn Hazard CPSC has received numerous reports highlighting the dangers...

Continue Reading
SWCA's New Hires Boost Tech and Financial Vision

Updated Category News Views 9

SWCA's Executive Shake-Up: A Strategic Play Not every day you see a company on a mission to revamp its future with fresh blood at the top. SWCA Environmental Consultants, based out of sunny Phoenix, just decided to shake things up at the C-suite level by roping in Dan Kieny as Chief Digital Information Officer and George Mekitarian as Chief Financial Officer. These moves...

Continue Reading